128 results
Page 4 of 7
8-K
EX-99.1
4m5ue7gs7syvwc63pob
11 Feb 20
FibroGen Announces U.S. FDA Acceptance of New Drug Application for Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
5:16pm
8-K
EX-99.1
31uevjppkc dh6blf2el
30 Jan 20
Astellas Submits Supplemental New Drug Application for Approval of
4:40pm
8-K
EX-99.1
g88 lx5bwfh
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
u1qrn1h
6 Jan 20
Fibrogen Names Enrique Conterno As Chief Executive Officer
5:23pm
8-K
EX-99.1
f38l1l m2j0sft
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
8-K
EX-99.1
sofbuek64vr79lo9cu
2 Dec 19
FibroGen Announces Roxadustat Inclusion in China’s National Reimbursement Drug List
7:10am
8-K
EX-99.1
a2a3 aw0zzln
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.2
n3zo4u 08zxb
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
1v9x49szk
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
x3yw kv8v
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
e9p1 x62ra0qjq8
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
u9kx0jn
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
3olz0o
20 Sep 19
Roxadustat Approved in Japan for the Treatment of Anemia Associated with Chronic Kidney Disease in Dialysis Patients
9:00am
8-K
EX-99.1
62vp8 yu0nw
26 Aug 19
Departure of Directors or Certain Officers
9:04am
8-K
EX-99.1
dqy74q 28t
21 Aug 19
Roxadustat Approved In China for Treatment of Anemia In Chronic Kidney Disease Patients Not Receiving Dialysis
4:39pm
8-K
EX-99.1
sg6ycjwpkhs0sqxyz4l
8 Aug 19
Fibrogen Reports Second Quarter 2019 Financial Results
4:15pm
8-K
EX-99.1
67fm 4m7f
24 Jul 19
Other Events
9:46pm
8-K
EX-99.2
6ht5e
24 Jul 19
Other Events
9:46pm